The amyloid deposition has long been considered one of the pathognomonic markers of Alzheimer’s disease (AD). Moreover, disruption in the amyloid hypothesis has been frequently discussed as an important target of intervention
Maximize the informational quality of your email inbox by selectively subscribing to evidence-based health and wellness resources that are informed by rigorous scientific research and medical expertise.
Your privacy is important to us
© 2020-2022 HealthSciaxis a Sciaxis Company. All rights reserved. Our website services, content, and products are for informational purposes only. HealthSciaxis does not provide medical advice, diagnosis, or treatment. See additional information.
